PFE PFE

Pfizer Share Price - PFE

54.01
3.12 (6.13%)
Upgrade to Real-Time
Afterhours (Closed)
54.01
Volume 66,561,359
Bid Price
Ask Price
News (8)
Day High 54.94

Low
33.36

52 Week Range

High
54.94

Day Low 53.25
Best deals to access real time data!
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
North American Extreme
Monthly Subscription
for only
US$104.50
USA Big Cap Pro
Monthly Subscription
for only
US$52.04
VAT not included
Stock Name Stock Symbol Market Stock Type
Pfizer Inc PFE NYSE Common Stock
  Price Change Price Change % Stock Price Last Trade
3.12 6.13% 54.01 15:59:45
Open Price Low Price High Price Close Price Previous Close
54.01 53.25 54.94 53.84 50.89
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
423,618 66,561,359 US$ 54.00 US$ 3,594,254,080 - 33.36 - 54.94
Last Trade Type Quantity Price Currency
16:00:00 2,181,016 US$ 54.00 USD

Period:

Draw Mode:

Pfizer Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 303.15B 5.61B 5.61B US$ 41.91B US$ 13.25B 1.71 14.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ 1.52 3.07% 11/04/21 43.70k 0.30%

more financials information »

Pfizer News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PFE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week51.9654.9450.3050.9629,678,1352.053.95%
1 Month43.0954.9442.85548.2543,982,00110.9225.34%
3 Months46.9454.9440.9445.7730,362,5667.0715.06%
6 Months39.3354.9438.47544.7030,604,83014.6837.33%
1 Year36.7854.9433.3640.8432,766,26917.2346.85%
3 Years43.3254.9427.8839.1028,339,41510.6924.68%
5 Years31.6954.9427.8838.1424,504,58422.3270.43%

Pfizer Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
Your Recent History
NYSE
PFE
Pfizer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211127 20:52:55